NANOVIRICIDES, INC. — Director's Dealing 2013

Jul 2, 2013

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NANOVIRICIDES, INC. (NNVC)
CIK: 0001379006
Period of Report: 2013-05-28

Reporting Person: BONIUK MILTON (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.001 per share	200000	Direct
Common Stock, par value $0.001 per share	666667	Indirect
Common Stock, par value $0.001 per share	666667	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants	$1.00	2014-06-30	Common Stock, par value $0.001 per share (100000)		Direct
Unsecured 8% Coupon Series B Convertible Debenture	$1.00	2017-01-31	Common Stock, par value $0.001 per share ()		Indirect
Unsecured 8% Coupon Series B Convertible Debenture	$1.00	2017-01-31	Common Stock, par value $0.001 per share ()		Indirect

Footnotes

F1: Includes 200,000 shares of common stock held in the name of the Reporting Person and his wife, Laurie Boniuk.

F2: Includes 666,667 shares of common stock held in the name of Boniuk Charitable Foundation, of which the Reporting Person holds voting and dispositive power.

F3: Includes 666,667 shares of common stock held in the name of Boniuk Investments Ltd., of which the Reporting Person holds voting and dispositive power.

F4: The warrants are presently exercisable and are held in the name of the Reporting Person and his wife, Laurie Boniuk.

F5: The debenture is presently exercisable and is held in the name of Boniuk Charitable Foundation, of which the Reporting Person holds voting and dispositive power.

F6: The debenture is presently exercisable and is held in the name of Boniuk Investments Ltd., of which the Reporting Person holds voting and dispositive power.

F7: The debentures are convertible into shares of the Issuer's Common Stock, at a conversion price of $1.00 per share plus interest in shares of restricted Common Stock.